Condition 1: coronary artery disease. Condition 2: obesity. Condition 3: blood pressure. Condition 4: diabet. Atherosclerotic heart disease of native coronary artery Obesity due to excess calories Examination of blood pressure Type 2 diabetes mellitus
Conditions
Interventions
Intervention 1: Intervention group: All patients in the intervention group are provided with a three-month short-term balanced diet by a nutritionist. This visit will last for at least half an hour an
Sponsors
Birjand University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: coronary artery disease with at least 50% stenosis BMI more than 30 patient satisfaction Age above 18 years
Exclusion criteria
Exclusion criteria: coronary artery disease with less than 50% stenosis BMI less than 30 patients with hyperthyroidism Any type of musculoskeletal and rheumatologic disease that prevents patients from walking Age under 18 years Any known cancers in patients Known chronic kidney disease in patients (such as types of glomerulonephritis or patients undergoing routine dialysis) Known liver disease in patients (such as types of viral hepatitis and autoimmune hepatitis) Immunocompromised patients People with disabilities Bedridden people
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Distance covered in the 6 Minutes Walking test. Timepoint: at 0 and 3 months after the intervention in the two investigated groups. Method of measurement: Checking the distance traveled during 6 minutes.;Level of fasting blood sugar. Timepoint: Time zero and 3 months after the intervention in the two studied groups. Method of measurement: Hospital laboratory kit.;Serum level of lipid profile (LDL, Chol, TG, HDL). Timepoint: Time zero and 3 months after the intervention in the two studied groups. Method of measurement: Hospital laboratory kit.;Serum levels of SGOT and SGPT. Timepoint: Time zero and3 months after the intervention in the two studied groups. Method of measurement: Hospital laboratory kit.;BMI and waist circumference. Timepoint: Time zero and 3 months after the intervention in the two studied groups. Method of measurement: scale and meter.;HbA1C. Timepoint: Time zero and 3 months after the intervention in the two studied groups. Method of measurement: Hospital laboratory kit.;Average systolic and diastolic blood pressure. Timepoint: Time zero and 3 months after the intervention in the two studied groups. Method of measurement: blood pressure device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzadeh Akbari
Birjand University of Medical Sciences
Outcome results
None listed